Name<\/strong><\/p>\n<\/td>\n Current Price<\/strong><\/p>\n<\/td>\n Fair Value (Est)<\/strong><\/p>\n<\/td>\n Discount (Est)<\/strong><\/p>\n<\/td>\n<\/tr>\n Tristel (AIM:TSTL)<\/p>\n<\/td>\n \u00a33.85<\/p>\n<\/td>\n \u00a37.59<\/p>\n<\/td>\n 49.3%<\/p>\n<\/td>\n<\/tr>\n RHI Magnesita (LSE:RHIM)<\/p>\n<\/td>\n \u00a328.85<\/p>\n<\/td>\n \u00a355.64<\/p>\n<\/td>\n 48.1%<\/p>\n<\/td>\n<\/tr>\n Playtech (LSE:PTEC)<\/p>\n<\/td>\n \u00a33.55<\/p>\n<\/td>\n \u00a36.65<\/p>\n<\/td>\n 46.6%<\/p>\n<\/td>\n<\/tr>\n Oxford Biomedica (LSE:OXB)<\/p>\n<\/td>\n \u00a36.18<\/p>\n<\/td>\n \u00a312.22<\/p>\n<\/td>\n 49.4%<\/p>\n<\/td>\n<\/tr>\n Mitie Group (LSE:MTO)<\/p>\n<\/td>\n \u00a31.77<\/p>\n<\/td>\n \u00a33.40<\/p>\n<\/td>\n 48%<\/p>\n<\/td>\n<\/tr>\n M&G (LSE:MNG)<\/p>\n<\/td>\n \u00a33.146<\/p>\n<\/td>\n \u00a36.19<\/p>\n<\/td>\n 49.2%<\/p>\n<\/td>\n<\/tr>\n Fevertree Drinks (AIM:FEVR)<\/p>\n<\/td>\n \u00a37.77<\/p>\n<\/td>\n \u00a314.94<\/p>\n<\/td>\n 48%<\/p>\n<\/td>\n<\/tr>\n Entain (LSE:ENT)<\/p>\n<\/td>\n \u00a35.386<\/p>\n<\/td>\n \u00a310.08<\/p>\n<\/td>\n 46.6%<\/p>\n<\/td>\n<\/tr>\n BTG Consulting (AIM:BTG)<\/p>\n<\/td>\n \u00a31.215<\/p>\n<\/td>\n \u00a32.38<\/p>\n<\/td>\n 49%<\/p>\n<\/td>\n<\/tr>\n B90 Holdings (AIM:B90)<\/p>\n<\/td>\n \u00a30.023<\/p>\n<\/td>\n \u00a30.045<\/p>\n<\/td>\n 48.6%<\/p>\n<\/td>\n<\/tr>\n Click here to see the full list of 56 stocks from our Undervalued UK Stocks Based On Cash Flows screener.<\/a><\/p>\n We’re going to check out a few of the best picks from our screener tool.<\/p>\n Overview:<\/strong> Oxford Biomedica plc is a contract development and manufacturing organization specializing in delivering therapies globally, with a market cap of \u00a3747.29 million.<\/p>\n Operations:<\/strong> The company’s revenue is derived from Development Services (\u00a360.11 million), Procurement Services (\u00a322.30 million), Manufacturing Services (\u00a381.06 million), and Licences, Milestones, and Royalties (\u00a35.27 million).<\/p>\n Estimated Discount To Fair Value:<\/strong> 49.4%<\/p>\n Oxford Biomedica is trading at \u00a36.18, significantly below its estimated future cash flow value of \u00a312.22, indicating it is undervalued based on discounted cash flows. Recent earnings showed a reduction in net loss from \u00a343.19 million to \u00a330.13 million, with revenue increasing to \u00a3168.74 million from the previous year\u2019s figure of \u00a3128.8 million. The company’s fast-track development offerings and strategic partnerships further enhance its growth potential and market positioning in viral vector manufacturing services globally.<\/p>\n Overview:<\/strong> Playtech plc is a technology company that provides gambling software, services, content, and platform technologies with a market cap of \u00a3986.36 million.<\/p>\n Operations:<\/strong> The company’s revenue primarily comes from its B2B segment, generating \u20ac688.30 million, with additional contributions from HAPPYBET at \u20ac12.20 million and Sun Bingo and Other B2C at \u20ac66.30 million.<\/p>\n Estimated Discount To Fair Value:<\/strong> 46.6%<\/p>\n Playtech is trading at \u00a33.55, significantly below its estimated future cash flow value of \u00a36.65, highlighting its undervaluation based on discounted cash flows. Despite a decrease in sales to \u20ac763.6 million from the previous year’s \u20ac848 million, Playtech reported a substantial net income turnaround to \u20ac1.48 billion from a prior net loss of \u20ac23.9 million. The recent SaaS agreement with Inspired Entertainment enhances Playtech’s virtual sports offerings and could drive further growth in revenue and profitability over time.<\/p>\n Overview:<\/strong> The Beauty Tech Group plc, along with its subsidiaries, offers at-home beauty devices across various regions including the United States, Canada, the United Kingdom, Ireland, Europe, and Asia; it has a market cap of \u00a3353.65 million.<\/p>\n Operations:<\/strong> Revenue segments for the company include Tria at \u00a31.95 million, Ziip at \u00a313.16 million, Currentbody at \u00a3125.78 million, and Third Party sales at \u00a30.08 million.<\/p>\n Estimated Discount To Fair Value:<\/strong> 26%<\/p>\n Beauty Tech Group is trading at \u00a33.33, over 20% below its estimated future cash flow value of \u00a34.5, indicating undervaluation based on discounted cash flows. The company reported a significant net income increase to \u00a39.93 million from \u00a31.7 million last year, with earnings per share rising substantially as well. Analysts expect earnings to grow significantly by 27.73% annually over the next three years, outpacing UK market growth expectations and supported by strong profit margins guidance for 2026.<\/p>\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.<\/strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.<\/p>\n Companies discussed in this article include LSE:OXB LSE:PTEC and LSE:TBTG.<\/p>\n This article was originally published by Simply Wall St<\/a>.<\/p>\n Have feedback on this article? Concerned about the content? Get in touch<\/a> with us directly.<\/strong> Alternatively, email editorial-team@simplywallst.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"The United Kingdom’s stock market has recently experienced a downturn, with the FTSE 100 closing lower amid weak…\n","protected":false},"author":2,"featured_media":985387,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[3,4],"tags":[748,24091,273922,393,24090,4884,273923,143168,1144,273921,62318,712,977,14315,16,24087,15,1764],"class_list":["post-985386","post","type-post","status-publish","format-standard","has-post-thumbnail","category-uk","category-united-kingdom","tag-britain","tag-cash-flows","tag-discounted-cash-flows","tag-england","tag-fair-value","tag-great-britain","tag-market-positioning","tag-mitie-group","tag-northern-ireland","tag-oxford-biomedica","tag-playtech","tag-scotland","tag-stock-market","tag-the-united-kingdom","tag-uk","tag-undervalued-stocks","tag-united-kingdom","tag-wales"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/116639643036732118","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/985386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=985386"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/985386\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/985387"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=985386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=985386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=985386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n ![\"LSE:OXB](\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2026\/05\/af2b1c8b9300c2c7bcee72c6a5decd79.png\")
<\/a> LSE:OXB Discounted Cash Flow as at May 2026 <\/p>\n<\/a> LSE:PTEC Discounted Cash Flow as at May 2026 <\/p>\n
<\/a> LSE:TBTG Discounted Cash Flow as at May 2026 Next Steps Searching for a Fresh Perspective? <\/p>\n